OUR MISSION
All Humans are Heterogeneous.

ROKIT Healthcare is a global Pioneer that transforms the healthcare paradigm.

We upgrade and expand the life span with our hyper-personal organ regeneration & anti-aging platform

All patients are different since all humans are heterogeneous. There is no one single therapy for all patients, so we provide suffering patients and humans with a hyper-personalized medical organ regeneration solution. Based on our expertise in regenerative medicine, we are commercializing a safer, more effective, and faster organ regeneration platform around the world.

Solution
Precision medicine-based personalized Organ Regeneration solution

In this era, a paradigm shift in medical economics is taking place, and expectations for precision medicine-based regenerative medical solutions are rising around the world. We apply Artificial Intelligence and 3D bioprinting technology to realistically regenerate the skin and cartilage organs with just-in-time surgery, allowing patients to have a high quality of life and extend their lives. We are always seeking medical partners around the world.

Join us in the creative and life-saving strife.

biomedical Innovation
Realize reverse aging beyond anti-aging

Innovate the bio-medical world for treating chronic diseases with Organ Regeneration Platform

Based on the cell heterogeneity of humans, we want to realize reverse aging beyond anti-aging for people by providing health supplements and medical devices developed through medical research.

With ROKIT Healthcare, you can drastically reduce the burden on patients and the medical economy that they have to pay to treat chronic diseases. We hope you can innovate the bio-medical world with ROKIT Healthcare’s organ regeneration platform together.

Milestones
2012
ROKIT, Inc. established.
2016 - 2017
· Launched world's first 4D Bioprinter Dr. INVIVO 4D2
· ROKIT EU established collaboration with Fraunhofer IBMT.
2019. 06.
· Secured US$30 million in investment.
2019. 07.
· ROKIT Genomics Inc. established. (KOREA)
· ROKIT America, Inc. established. (USA)
2019. 08.
· Conducted Skin & DFU regeneration clinical trial - Hycare Hospital in India
2019. 11.
· Joint research on cartilage - Massachusetts General Hospital in USA.
· Awarded tech challenge award in AAPS.
2019. 12.
· Selected as top 50 healthcare company in IFAH.
2020. 04.
· Conducted Skin & DFU regeneration clinical trial - Korea University Guro Hospital.
2020. 07.
Attracted investments from DRADS Capital.
2020. 10.
· Conducted Cartilage regeneration clinical trial - Assiut Medical University.
2020. 12.
· Conducted DFU regeneration clinical trial in the US PI: Dr. David Armstrong.
2021.
· Skin Regeneration Platform global partnership – Mexico, Turkey, Korea, India.
2021. 03.
· First KIT export to Cigalah UAE.
2021. 04.
· Conducted DFU & Burn clinical trial - Ankara City Hospital in Turkey.
2021. 05.
· Conducted DFU clinical trial - UKM Hospital in Malaysia.
2021. 10.
· Presented US DFU clinical data awarded 3rd place in DFCON.
2022.
· Export skin regeneration kit to India, Brazil, Paraguay.
2022. 02.
· Scaffold Kit US FDA registration.
2022. 04.
· Conducted skin cancer clinical trial – Korea University Guro Hospital.